Matti Nykter
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 2%
- Immunology top 5%
- Co-authors
- Matti AnnalaIlya ShmulevichAlexander W. WyattKim N.Kevin BejaDavid CogdellMartin GleaveTapio Visakorpi
- Topics
- Prostate Cancer Treatment and Research (32 papers)Cancer Genomics and Diagnostics (21 papers)Glioma Diagnosis and Treatment (15 papers)
- Journals
- Proceedings of the National Academy of SciencesPhysical Review LettersNucleic Acids Research
- Partner nations
- FinlandUnited StatesCanada
In The Last Decade
Matti Nykter
146 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Molecular Biology 3.0k
- Cancer Research 2.4k
- Pulmonary and Respiratory Medicine 1.9k
- Oncology 988
- Immunology 456
Countries citing papers authored by Matti Nykter
This map shows the geographic impact of Matti Nykter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Nykter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Nykter more than expected).
Fields of papers citing papers by Matti Nykter
This network shows the impact of papers produced by Matti Nykter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Nykter. The network helps show where Matti Nykter may publish in the future.
Co-authorship network of co-authors of Matti Nykter
This figure shows the co-authorship network connecting the top 25 collaborators of Matti Nykter. A scholar is included among the top collaborators of Matti Nykter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Nykter. Matti Nykter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 3 | |
| 5 | 6 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 52 | |
| 9 | 8 | |
| 10 | 26 | |
| 11 | 8 | |
| 12 | 37 | |
| 13 | 12 | |
| 14 | 42 | |
| 15 | 19 | |
| 16 | 54 | |
| 17 | Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancerbreakdown → | 347 |
| 18 | 41 | |
| 19 | 58 | |
| 20 | 44 |
About Matti Nykter
Matti Nykter is a scholar working on Cancer Research, Genetics and Molecular Biology, having authored 152 papers that have together received 5.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (32 papers), Cancer Genomics and Diagnostics (21 papers) and Glioma Diagnosis and Treatment (15 papers). The work is most often cited by research in Cancer Research (2.4k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Molecular Biology (3.0k citations). Matti Nykter has collaborated with scholars based in Finland, United States and Canada. Frequent co-authors include Matti Annala, Ilya Shmulevich, Alexander W. Wyatt, Kim N., Kevin Beja, David Cogdell, Martin Gleave, Tapio Visakorpi, Kexin Chen and Olli Yli‐Harja. Their work appears in journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.